Literature DB >> 8903081

Primary diffuse leptomeningeal gliomatosis with signs of increased intracranial pressure and progressive meningeal enhancement on MRI.

J S Park1, S van den Noort, R C Kim, I Walot, H Licht.   

Abstract

A 21-year-old woman presented with a 5-month history of meningeal signs and evidence of intracranial hypertension and, as shown by magnetic resonance imaging (MRI), progressively more extensive meningeal enhancement, particularly within the spinal canal. Autopsy disclosed the presence of primary diffuse leptomeningeal gliomatosis with spinal cord predominance, possibly arising within heterotopic leptomeningeal glial tissue in the cervical region. No parenchymal primary lesion was identified. MRI with gadolinium appears to be the imaging modality of choice for the early detection of primary diffuse leptomeningeal neoplasia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8903081     DOI: 10.1111/jon199664250

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  4 in total

1.  A case report and review of the literature.

Authors:  Shoji Yomo; Tsuyoshi Tada; Shuichi Hirayama; Naoko Tachibana; Masako Otani; Yuichiro Tanaka; Kazuhiro Hongo
Journal:  J Neurooncol       Date:  2006-09-20       Impact factor: 4.130

2.  A case of primary leptomeningeal gliomatosis confined to the spinal cord.

Authors:  Robin Bhatia; Federico Roncaroli; Piers Thomas; Shie-Lee Cheah; Amrish Mehta; Mark Glaser; Christian Ulbricht
Journal:  J Neurooncol       Date:  2009-11-08       Impact factor: 4.130

Review 3.  Diffuse leptomeningeal gliomatosis initially presenting with intraventricular hemorrhage: a case report and literature review.

Authors:  Min Zhu; JunJun Zheng; Yuanzhao Zhu; Hui Wan; Yuchen Wu; Daojun Hong
Journal:  BMC Neurol       Date:  2015-05-10       Impact factor: 2.474

4.  Primary diffuse leptomeningeal gliomatosis as a rare cause of pain in cervical spine.

Authors:  Štefan Sivák; Ema Kantorová; Egon Kurča; Juraj Marcinek; Pavol Slávik; Jozef Michalik; Vladimír Nosáľ
Journal:  BMC Cancer       Date:  2016-03-04       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.